课题基金 / 基金详情

Study for roles of inflammatory cells and cytokines in asthma death, COPD and mouse pulmonary disease models

Study for roles of inflammatory cells and cytokines in asthma death, COPD and mouse pulmonary disease models
炎症细胞和细胞因子在哮喘死亡、慢性阻塞性肺病和小鼠肺部疾病模型中的作用研究
批准号:
21590977
负责人:
HOSHINO Tomoaki
金额:
$2.91万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2009
资助国家:
日本
项目状态:
已结题
起止时间:
2009 至 2011

项目摘要

项目成果

HOSHINO Tomoaki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Background : Eosinophils, CD4+T cells, and Th2 cytokines are thought to contribute to the development of asthma. Recently, a paper reported that pro-inflammatory IL-18 gene polymorphism was significantly associated with the disease severity of bronchial asthma. However, the detail of airway inflammation process in the lungs of nonsmoker asthma death has not reported.Method : We obtained lung tissues from 12 nonsmokers who died of asthma at autopsy. They died from 1973 to 1998.Lung tissues were also obtained from 5 well-controlled mild asthma patients and 10 nonsmokers who underwent lung cancer extirpation. We examined pulmonary inflammatory cells, and also evaluated the expression of IL-18 and its receptor in the lungs.Result : The numbers of eosinophils and lymphocytes, but not basophils, nor macrophages were significantly and greatly increased in the lungs when compared with mild asthmatics and nonsmokers. Interestingly, neutrophils were not significantly different when comparing fatal and mild asthmas, but were significantly increased in the lungs of asthma deaths than seen in nonsmokers. CD8+T cells but not CD4+T cells were significantly and greatly increased in the lungs of fatal asthma patients when compared to mild asthmas and nonsmokers. IL-18 proteins were strongly expressed in the bronchoalveolar epithelial cells and pulmonary inflammatory cells in asthma deaths. Moreover, IL-18Rαproteins were enhanced in the pulmonary inflammatory cells, especially CD8+T cells in the lungs of asthma death.Conclusion : CD8+T cells, eosinophils and over-expressed IL-18 proteins in the lungs may play an important role in the pathogenesis of asthma death.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of proinflammatory cytokines in respiratory diseases.
促炎细胞因子在呼吸系统疾病中的作用。
DOI: --
发表时间: 2010
期刊:
影响因子: --
作者: [奥山香織, 和田佳奈, 河野資, 大河原雄一, 田村弦, 曽良一郎, 高柳元明, 大野勲, Hoshino T]
通讯作者: Hoshino T
DOI: 10.1186/ar3295
发表时间: 2011-03-24
期刊: Arthritis research & therapy
影响因子: 4.9
作者: [Takei S, Hoshino T, Matsunaga K, Sakazaki Y, Sawada M, Oda H, Takenaka S, Imaoka H, Kinoshita T, Honda S, Ida H, Fukuda TA, Aizawa H]
通讯作者: Aizawa H
Interleukin-18 and interleukin-18 receptor-alpha expression in allergic asthma
过敏性哮喘中白细胞介素 18 和白细胞介素 18 受体 α 的表达
DOI: --
发表时间: 2011
期刊: Eur Respir J
影响因子: 24.3
作者: [Imaoka H, Gauvreau GM, Watson RM, Smith SG, Dua B, Baatjes AJ, Howie K, Hoshino T, Killian KJ, Aizawa H, O' Byrne PM]
通讯作者: O' Byrne PM
DOI: 10.1371/journal.pone.0024177
发表时间: 2011
期刊: PloS one
影响因子: 3.7
作者: [Sakazaki Y, Hoshino T, Takei S, Sawada M, Oda H, Takenaka S, Imaoka H, Matsunaga K, Ota T, Abe Y, Miki I, Fujimoto K, Kawayama T, Kato S, Aizawa H]
通讯作者: Aizawa H
9
    Study for roles of IL-18 in interstitial lung diseases and lung remodeling
    • 批准号:
      15390261
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.19万
    • 财政年份:
      2003
    • 负责人:
      HOSHINO Tomoaki
    • 依托单位:
    Basic Research for Prevention of Interstitial Lung Diseases Induced by IL-18
    • 批准号:
      13670622
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.3万
    • 财政年份:
      2001
    • 负责人:
      HOSHINO Tomoaki
    • 依托单位:
    Molecular immunological analysis for IgE production and a unique NK cell population producing type 2 cytokine, IL-13
    • 批准号:
      11670468
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.18万
    • 财政年份:
      1999
    • 负责人:
      HOSHINO Tomoaki
    • 依托单位:
    国内基金
    海外基金
    电针通过LONP1/BOK调控线粒体-内质网结构偶联抑制肺泡上皮细胞ISR改善COPD肺损伤和炎症的机制研究
    • 批准号:
      JCZRQNB202600509
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    稳定期COPD中医证型的脂代谢紊乱特征及PPARγ/CPT1A调控机制及临床研究
    • 批准号:
      JCZRLH202601649
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    基于“组蛋白乳酸化修饰调控肺泡巨噬细胞极化”研究肺气肿型COPD炎症机制及补肺汤干预作用
    补肺康方调控PI3K/Akt通路重编程巨噬细胞极化治疗COPD肺脾气虚证的机制及临床研究